SCM Lifescience Co., Ltd. (KOSDAQ:298060)

SCM Lifescience Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	52,513	38,704	77,366	175,143	233,826	586,015
Market Cap Growth	27.02%	-49.97%	-55.83%	-25.10%	-60.10%	-
Enterprise Value	43,615	40,480	65,415	170,464	217,178	551,155
Last Close Price	1188.00	1891.00	3780.00	10694.08	14394.46	36522.70
PS Ratio	34.03	46.93	111.21	442.30	532.32	1831.26
PB Ratio	2.15	2.73	3.78	7.15	5.24	9.29
P/TBV Ratio	2.19	2.87	3.82	7.24	5.28	9.34
EV/Sales Ratio	28.27	49.08	94.03	430.49	494.42	1722.33
Debt / Equity Ratio	0.11	0.49	0.19	0.24	0.14	0.11
Asset Turnover	0.06	0.03	0.02	0.01	0.01	0.01
Inventory Turnover	2.38	1.10	1.53	1.29	0.85	0.55
Quick Ratio	6.34	0.18	10.85	1.97	2.27	10.85
Current Ratio	6.61	0.35	11.55	2.20	2.33	11.07
Return on Equity (ROE)	-41.87%	-71.44%	-106.53%	-66.34%	-41.82%	-23.08%
Return on Assets (ROA)	-21.08%	-29.10%	-27.81%	-18.06%	-11.66%	-17.14%
Return on Capital (ROIC)	-22.35%	-31.11%	-29.77%	-19.40%	-12.61%	-20.68%
Earnings Yield	-15.69%	-31.98%	-30.97%	-13.09%	-9.63%	-1.64%
FCF Yield	-31.52%	-36.50%	-15.99%	-6.67%	-6.02%	-2.11%
Buyback Yield / Dilution	-10.66%	-25.01%	-12.85%	-21.21%	-12.79%	-101.51%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.